Chargement en cours...
Methodology to Incorporate Biologically Effective Dose and Equivalent Uniform Dose in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin Lymphoma Patients Targeted with (131)I-Tositumomab Therapy
A 3-dimensional (3D) imaging–based patient-specific dosimetry methodology incorporating antitumor biologic effects using biologically effective dose (BED) and equivalent uniform dose (EUD) was developed in this study. The methodology was applied to the dosimetry analysis of 6 non-Hodgkin lymphoma pa...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3296121/ https://ncbi.nlm.nih.gov/pubmed/20237032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.109.067298 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|